Describing the chief complaints in a mobile, primary care clinic in Haiti: Using data to enlighten the knowledge of the burden of non-communicable diseases
Method: From 2008 to 2012, nine temporary, primary-care clinics were setup in the following four locations in Haiti. Demographic information as well as chief complaints, diagnoses, and treatment are documented in the medical chart for each patient. Data was collected on a total of 949 patients. From this cross-sectional sampling, statistical analyses will be performed to assess statistical differences based on demographic characteristics and NCD prevalence.
Results: Preliminary analyses show that out of 634 adult patients seen from 2008-2012, 77.9% were female and 56.5% were from an urban setting (Carrefour and Port-au-Prince). The most commonly reported NCDs included GERD (18.8%), hypertension (15.5%), anemia (12.1%), diabetes mellitus (6.0%), and arthritis (2.7%).
Conclusion: The increase in incidence and prevalence of NCDs is impacting Haiti, but the burden of this shift is still unknown. Improving the surveillance system will contribute to the design of more effective health strategies, prevention programs, and the identification of underlying causes in NCDs.
Learning Areas:Chronic disease management and prevention
Describe the main, chief complaints in a primary care setting in Haiti Identify the main health care needs in both urban and rural populations in Haiti Evaluate if there is any difference in NCD prevalence between the urban and rural populations in Haiti
Keyword(s): Health Assessment, Chronic Diseases
Qualified on the content I am responsible for because: I have more then 25 years experience in the different areas of public health: academia, research, community health, global health
I was the PI for as asthma surveillance project funded by the CDC from 2001-2006
Currently, Im an assistant professor in Public health
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.